At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 113 enrolled
Drug / intervention
Elidel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
In Brief
A Phase 2 clinical trial evaluating Elidel and Ketoconazole Cream for Seborrheic Dermatitis. Completed, enrolled 113 participants across 1 site.
Detailed Summary
This is an exploratory study to determine effectiveness of Elidel for the treatment of seborrheic dermatitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeborrheic Dermatitis
CountriesUnited States
CollaboratorsNovartis
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 2006
Enrollment StartMay 2007
Primary CompletionFeb 2009
Study CompletionFeb 2009
TodayJul 2026
First PostedNov 23, 2006
Enrollment StartMay 7, 2007
Primary CompletionFeb 20, 2009
Study CompletionFeb 27, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 19.6 years ago
Interventions
Elideldrug
Ketoconazole Creamdrug